Daphne Karydas

Director, Mineralys Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.9M

Companies

Latest trade

Sep 15, 2026

Companies

Mineralys Therapeutics, Inc.Director −$0.9M

Trades

MLYS Sold 3,000 shares at $28.58 · planned $0.1M Sep 15

MLYS Sold 3,000 shares at $25.00 · planned $0.1M Jun 17

MLYS Sold 3,000 shares at $25.00 · planned $0.1M Mar 31

MLYS Sold 15,000 shares at $45.99 $0.7M Nov 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.